CRVS icon

Corvus Pharmaceuticals
CRVS

Overview Fund Activity

52 hedge funds and large institutions have $44.6M invested in Corvus Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 7 closing their positions.

Holders
52
Holders Change
+15
Holders Change %
+40.54%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
11
Reduced
6
Closed
7
Calls
$266K
Puts
$272K
Net Calls
-$6K
Net Calls Change
-$15K

Top Buyers

1
SC
1
Samlyn Capital
New York
$4.82M
2
Marshall Wace
2
Marshall Wace
United Kingdom
$685K
3
TL
3
TowerView LLC
New York
$469K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$447K
5
MA
5
MYDA Advisors
New York
$229K

Top Sellers

1
CA
1
CHI Advisors
New York
$458K
2
Millennium Management
2
Millennium Management
New York
$0
3
DCM
3
Discovery Capital Management
Connecticut
$0
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$132K
5
BCM
5
Bridgeway Capital Management
Texas
$250K
Name Holding Trade Value Shares
Change 		Shares
Change %
PA
51
Parallel Advisors
California
$46 – – –
Millennium Management
52
Millennium Management
New York
– -$1.85M -2,029,423 Closed
DCM
53
Discovery Capital Management
Connecticut
– -$499K -548,727 Closed
LP
54
LMR Partners
United Kingdom
– -$27.3K -30,000 Closed
BBA
55
Baader Bank Aktiengesellschaft
Germany
– -$17.7K -24,911 Closed
Mercer Global Advisors
56
Mercer Global Advisors
Colorado
– -$10K -10,550 Closed
Envestnet Asset Management
57
Envestnet Asset Management
Illinois
– -$9.56K -10,500 Closed
TWA
58
TCI Wealth Advisors
Arizona
– -$455 -500 Closed
1 2
3